Prevalence of hypocalcemia in neonates receiving phototherapy: a systematic review and meta-analysis
5 affiliations
- 1Department of Neonatal Nursing, Asrat Weldeyes Health Science Campus, Debre Berhan University, Debre Berhan, Ethiopia
- 2School of Medical Laboratory Sciences, Asrat Weldeyes Health Science Campus, Debre Berhan University, Debre Berhan, Ethiopia
- 3School of Medical Laboratory Sciences, College of Medicine and Health Sciences, Wollo University, Dessie, Ethiopia
- 4Department of Midwifery, Asrat Weldeyes Health Science Campus, Debre Berhan University, Debre Berhan, Ethiopia
- 5ALKAN Health Science Business and Technology College, Dessie Campus, Dessie, Ethiopia
Abstract
Background: Although phototherapy is the standard treatment for neonatal hyperbilirubinemia, its adverse effects cause electrolyte disturbances. Aggregated evidence regarding the prevalence of phototherapy-induced hypocalcemia remains inconsistent across studies. Therefore, this systematic review and meta-analysis aimed to determine the pooled incidence hypocalcemia in neonates receiving phototherapy.
Methods: This systematic review and meta-analysis were conducted in compliance with the 2020 PRISMA guidelines. Relevant databases were searched to retrieve observational studies reporting hypocalcemia among neonates with hyperbilirubinemia through February 2026. The retrieved articles were cleaned for duplicates and selected based on the eligibility criteria. STATA 17.0 software was used to compute the pooled hypocalcemia with 95% confidence intervals via a random effects model. Heterogeneity was assessed via the I2 statistic and Cochran's Q test, whereas robustness was evaluated via leave-one-out sensitivity analysis and subgroup analysis. Furthermore, publication bias was assessed by Egger's regression test, Begg's rank correlation test, and trim-and-fill correction.
Results: In total, 25 studies involving 2673 neonates were included in the meta-analysis. The pooled prevalence of hypocalcemia in neonates undergoing phototherapy was estimated to be 20.68% (95% CI: 15.75–25.60%). There was significant heterogeneity (I2 = 94.15%, p < 0.001). In the subgroup analysis, there was a greater hypocalcemia in studies with preterm (23.03%, 95% CI: 14.18% – 31.88%) and low birth weight (22.57%, 95% CI: 14.99% – 30.16%) neonates than in those with term (18.51%, 95% CI: 12.39% – 24.63%) and normal birth weights (13.97%, 95% CI: 8.72% – 19.17%). The hypocalcemia was higher in Africa (36.00%, 95% CI: 7.52% – 64.47%) than in Asia (18.89%, 95% CI: 14.02% – 23.76%). Egger’s test revealed significant publication bias (p < 0.0001), with no significant change in the original effect size after trim-and-fill analysis.
Conclusion: Hypocalcemia is a frequent electrolyte disorder in neonates under phototherapy with neonatal hyperbilirubinemia. Thus, regular monitoring is essential, particularly for those who are at high risk.
Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s12887-026-07442-w.
Related
- Phototherapy-Associated Changes in Ionized Calcium Among Neonates Born at ≥35 Weeks of Gestation.
- Infectious Complications in Adults Receiving Extracorporeal Membrane Oxygenation: A Systematic Review and Meta-Analysis of Nosocomial and Bloodstream Infection, Prevalence, Risk Factors, and Clinical Outcomes.
- Preventive strategies for postoperative hypocalcemia and hungry bone syndrome following parathyroidectomy: a systematic review and pairwise meta-analysis
- Prevalence and associated factors of vitamin B12 deficiency among Vietnamese patients with type 2 diabetes receiving metformin therapy: a cross-sectional study
- Traumatic intracranial lesion prevalence in CT-imaged adults with mild traumatic brain injury receiving dual versus single antiplatelet therapy: a two-center cohort study
BibTeX
@article{belayhun2026prevalence,
title = {{Prevalence of hypocalcemia in neonates receiving phototherapy: a systematic review and meta-analysis}},
author = {Endashaw Belayhun and Mahider Shimelis Feyisa and Marye Wondimnew Tefera and Mihret Tilahun and Mikiyas Shemelis Achame and Rahel Birhanu Arage and Saleamlak Sebsibe and Sisay Desale and Sisay Kassa and Yabsira Asmare and Yonas Erkihun and Zewudu Mulatie and Bruktawit Eshetu and Afewerk Habtamu},
journal = {BMC Pediatrics},
year = {2026},
month = jul,
doi = {10.1186/s12887-026-07442-w},
url = {https://doi.org/10.1186/s12887-026-07442-w},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Prevalence of hypocalcemia in neonates receiving phototherapy: a systematic review and meta-analysis
AU - Endashaw Belayhun
AU - Mahider Shimelis Feyisa
AU - Marye Wondimnew Tefera
AU - Mihret Tilahun
AU - Mikiyas Shemelis Achame
AU - Rahel Birhanu Arage
AU - Saleamlak Sebsibe
AU - Sisay Desale
AU - Sisay Kassa
AU - Yabsira Asmare
AU - Yonas Erkihun
AU - Zewudu Mulatie
AU - Bruktawit Eshetu
AU - Afewerk Habtamu
PY - 2026
DA - 2026/07/31
JO - BMC Pediatrics
DO - 10.1186/s12887-026-07442-w
UR - https://doi.org/10.1186/s12887-026-07442-w
AB - Background: Although phototherapy is the standard treatment for neonatal hyperbilirubinemia, its adverse effects cause electrolyte disturbances. Aggregated evidence regarding the prevalence of phototherapy-induced hypocalcemia remains inconsistent across studies. Therefore, this systematic review and meta-analysis aimed to determine the pooled incidence hypocalcemia in neonates receiving phototherapy. Methods: This systematic review and meta-analysis were conducted in compliance with the 2020 PRISMA guidelines. Relevant databases were searched to retrieve observational studies reporting hypocalcemia among neonates with hyperbilirubinemia through February 2026. The retrieved articles were cleaned for duplicates and selected based on the eligibility criteria. STATA 17.0 software was used to compute the pooled hypocalcemia with 95% confidence intervals via a random effects model. Heterogeneity was assessed via the I2 statistic and Cochran's Q test, whereas robustness was evaluated via leave-one-out sensitivity analysis and subgroup analysis. Furthermore, publication bias was assessed by Egger's regression test, Begg's rank correlation test, and trim-and-fill correction. Results: In total, 25 studies involving 2673 neonates were included in the meta-analysis. The pooled prevalence of hypocalcemia in neonates undergoing phototherapy was estimated to be 20.68% (95% CI: 15.75–25.60%). There was significant heterogeneity (I2 = 94.15%, p < 0.001). In the subgroup analysis, there was a greater hypocalcemia in studies with preterm (23.03%, 95% CI: 14.18% – 31.88%) and low birth weight (22.57%, 95% CI: 14.99% – 30.16%) neonates than in those with term (18.51%, 95% CI: 12.39% – 24.63%) and normal birth weights (13.97%, 95% CI: 8.72% – 19.17%). The hypocalcemia was higher in Africa (36.00%, 95% CI: 7.52% – 64.47%) than in Asia (18.89%, 95% CI: 14.02% – 23.76%). Egger’s test revealed significant publication bias (p < 0.0001), with no significant change in the original effect size after trim-and-fill analysis. Conclusion: Hypocalcemia is a frequent electrolyte disorder in neonates under phototherapy with neonatal hyperbilirubinemia. Thus, regular monitoring is essential, particularly for those who are at high risk. Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s12887-026-07442-w.
SN - 1471-2431
ER -